Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07087587 · ClinicalTrials.gov registry record · NA
Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
A NA study of Afib and CPAP, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT07087587 is a NA study of Afib and CPAP that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 20 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07087587, a NA study of Afib and CPAP, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
A pilot N-of-1 randomized controlled trial evaluating the effectiveness of a personalized CPAP intervention in reducing atrial fibrillation (AF) burden and improving AF-related quality of life in patients with moderate to severe obstructive sleep apnea (OSA).
Conditions Studied
Interventions
- DEVICE CPAP
Study Locations (2)
Ohio
- Cleveland Clinic - Cleveland
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07087587
The ClinicalTrials.gov registry entry for NCT07087587 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Afib appearing as the primary indexed condition, and to 1 intervention - of which CPAP is the first listed.
NCT07087587 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Washington.
Frequently Asked Questions
What is clinical trial NCT07087587 about?
NCT07087587 is a clinical study titled "Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):". A pilot N-of-1 randomized controlled trial evaluating the effectiveness of a personalized CPAP intervention in reducing atrial fibrillation (AF) burden and improving AF-related quality of life in patients with moderate to severe obstructive sleep apnea (OSA).
What is the current status of trial NCT07087587?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-08-25. Estimated completion is 2026-05-31.
What conditions does trial NCT07087587 study?
This clinical trial studies the following conditions: Afib, CPAP, Sleep Apnea Syndrome, Obstructive.
What interventions are being tested in trial NCT07087587?
The interventions under investigation include: CPAP (DEVICE).
Who is sponsoring clinical trial NCT07087587?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07087587 being conducted?
This trial has 2 study locations across Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Afib
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.